New discovery may lead to immunization against cardiovascular disease

Jul 31, 2008

Low levels of naturally occurring antibodies may represent an increased risk of developing cardiovascular disease, particularly stroke in men. This discovery, published in the academic journal Atherosclerosis, has now led to attempts to develop an immunization against cardiovascular disease.

Atherosclerosis (hardening of the arteries) is an inflammatory disease in which the walls of the blood vessels are thickened and become less elastic. It can cause blood clots and other cardiovascular diseases. It is not known precisely what causes atherosclerosis, but the immune system probably plays an important role. Research scientists suspect that various oxidised forms of what is known as bad cholesterol, LDL (low-density lipoprotein), contribute to the development of the disease. A research team from Karolinska Institutet, in cooperation with Lund University, has now shown that a particular type of naturally occurring antibodies, anti-PC, which are targeted against the lipid portion of the LDL molecule, play an important role in the development of cardiovascular disease.

The findings show that individuals who have low levels of anti-PC are at increased risk of cardiovascular disease. The risk is particularly high in men who develop stroke, with an almost fourfold increase.

This newly discovered risk factor, low levels of anti-PC, is independent of previously known risk factors such as high blood pressure, high blood lipids, diabetes and smoking.

"Our findings suggest that anti-PC can be used as a complement to the traditional risk factors to improve diagnosis and treatment. In addition we are currently developing anti-PC as a vaccine for atherosclerosis and cardiovascular disease," says Professor Johan FrostegÄrd, who directed the study.

The study is based on data from 349 people who at some time over a 12-year period have suffered a heart attack or stroke and 693 individuals without symptoms of cardiovascular disease. The research has been carried out under the EU consortium CVDIMMUNE, www.cvdimmune.com/, which is led by Johan FrostegÄrd at Karolinska Institutet.

Source: Karolinska Institutet

Explore further: Dengue cases soar in Brazil, as death toll climbs

Related Stories

Claims about the decline of the West are 'exaggerated'

5 hours ago

A new paper by Oxford researchers argues that some countries in Western Europe, and the USA, Canada, Australia and New Zealand now have birth rates that are now relatively close to replacement, that the underlying trend in ...

Norway tests out 'animal rights cops'

6 hours ago

Norwegian police is creating a unit to investigate cruelty to animals, the government said Monday, arguing that those who hurt animals often harm people too.

Recommended for you

Dengue cases soar in Brazil, as death toll climbs

4 hours ago

Cases of dengue have soared in Brazil where the disease has caused 229 fatalities this year, the Health Ministry said Monday, as authorities try to combat its spread using transgenic mosquitos.

Meningitis epidemic kills more than 250 in Niger

6 hours ago

A meningitis epidemic in poverty-stricken Niger has claimed 252 lives since January, a health official said Monday, warning the country was short of vaccines to fight the outbreak.

New hope for short bowel syndrome

12 hours ago

Researchers at Children's Hospital Los Angeles have successfully made a small intestine that has the structural and molecular components of a healthy intestine.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

deatopmg
1 / 5 (1) Jul 31, 2008
There is a VERY VERY low, okay nil, probability of this EVER becoming a treatment. After this anouncement the whole subject will just vanish. There is just way to much money at stake for the medical cartel, big pharma and the medical industry, to allow this work to proceed. The cartel does it's best to keep us cronically ill and cronically treated to maximize their income.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.